Overview

Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
This study will compare insulin lispro protamine suspension (ILPS) and insulin glargine in combination with the patient's oral diabetes medications and exenatide, for their ability to control blood sugar in patients with type 2 diabetes.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Exenatide
Insulin
Insulin Glargine
Insulin Lispro
Insulin, Globin Zinc
Protamines